Gene · 5978
Papers4,251
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,251
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Causes and effects of fitness landscapes in system test generation: a replication study. | Autom Softw Eng | 2026 | 40980056 | PubTator, text mining | PubMed |
| More Than Just Antinuclear Antibodies: IgG Sialylation May Tip the Balance in Autoimmunity. | Arthritis Rheumatol | 2026 | 40931873 | PubTator, text mining | PubMed |
| Novel Pathogenic Variant Confirms the Association of REST and Jones Syndrome. | Clin Genet | 2026 | 40605398 | PubTator, text mining | PubMed |
| REST missense mutations reveal disrupted Re1 motif binding and co-repressor interactions in uterine fibroids. | Front Bioinform | 2025 | 41601477 | PubTator, text mining | PubMed |
| Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma. | Int J Mol Sci | 2025 | 41465373 | PubTator, text mining | PubMed |
| Design and validation of a flexible framework for developing generic digital twins for Industry 4.0. | Sci Rep | 2025 | 41444261 | PubTator, text mining | PubMed |
| Decoding Gene Responsiveness to Synthetic Chromatin Reader-Actuators with Multi-Modal Epigenomic Profiling. | bioRxiv | 2025 | 41394756 | PubTator, text mining | PubMed |
| OPRK1 drives SLC9A3R1 progression to neuroendocrine prostate cancer. | Cell Death Dis | 2025 | 41353213 | PubTator, text mining | PubMed |
Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals. | Res Sq | 2025 | 41333412 | PubTator, text mining | PubMed |
| Molecular effects of transposable element sequences in mammalian cells. | Genome Biol | 2025 | 41299541 | PubTator, text mining | PubMed |
| Immune cell-based transcriptomic Mendelian randomization and colocalization study on type 1 diabetes. | BMC Med | 2025 | 41299435 | PubTator, text mining | PubMed |
| QTFPred: robust high-performance quantum machine learning modeling that predicts main and cooperative transcription factor bindings with base resolution. | Brief Bioinform | 2025 | 41294241 | PubTator, text mining | PubMed |
| The Dynamic Roles of Repressor Element 1-Silencing Transcription Factor (REST): A Double-Edged Sword in Neural Health and Disease. | Mol Neurobiol | 2025 | 41239142 | PubTator, text mining | PubMed |
| Defining a Domain-Specific Language for Behavior Verification of Cyber-Physical Applications. | Sensors (Basel) | 2025 | 41228943 | PubTator, text mining | PubMed |
| Harnessing metabolic control for synaptic stability: REST/NRSF links glycolytic inhibition to excitatory neurotransmission. | J Physiol | 2025 | 41071623 | PubTator, text mining | PubMed |
| Tamoxifen attenuates manganese-induced dysregulation of neuronal REST via the genomic ER-α mechanism. | Front Mol Neurosci | 2025 | 41030314 | PubTator, text mining | PubMed |
| Shared immune biomarkers in necrotizing enterocolitis and neonatal sepsis identified via bioinformatics and machine learning. | Sci Rep | 2025 | 41006466 | PubTator, text mining | PubMed |
| Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity. | BMC Genomics | 2025 | 40999364 | PubTator, text mining | PubMed |
| Super-silencers are crucial for development and carcinogenesis in B cells. | Nat Commun | 2025 | 40998810 | PubTator, text mining | PubMed |
| Ligands binding diffusively to protein target act as inhibitors of protein-protein interactions. | PLoS Comput Biol | 2025 | 40961160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5978/papers?page=5